Cochlear chases Chinese sales
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
The head of medical device maker Cochlear believes the firm’s next great growth phase will come through expansion in China as the world’s second largest economy boosts healthcare spending, The Australian reports.
Cochlear chief executive Chris Roberts said the ASX-listed firm was in a position to capitalise on expectations China will spend $1 trillion on healthcare over the next six years as its population ages.
“The opportunity for Cochlear in China is really among the growing middle class, which is emerging here,” he told The Australian.
“There is not any projection that says the middle class will stop growing. A significant feature, also, is that China’s population is ageing.
“Most of our business is children but if you look at hearing loss, it doubles at each decade in age. As the Chinese population ages, the prevalence of hearing loss is naturally going to increase.”
Call 1300 880 160
Start a chat
Schedule a call
